Browse treatments

…ression pathways and cell interactions that underlie successful immunotherapy responses. We report a novel pipeline to register and systemati…

… largest HNSCC SCRNAseq cohort to date. Preliminary findings in immunotherapy resistant tumors compared to treatment-naïve HNSCC revealed dif…

…improved event-free survival (EFS) when adding immunotherapy to stereotactic ablative radiotherapy (SABR) for early-stage inoperable non-small cell lung cancer (N…

…t (TME). These modifications can also influence the efficacy of immunotherapy. Among the various PTMs, lactylation (Kla) is an emerging and n…

…ce (NICE) guideline for NSCLC,1 published in 2019, incorporated immunotherapy as a standard treatment option for patients with stage 3B–4B NS…

…ressive cells and induction of immunogenic cell death. However, chemotherapy exposure is also associated with lasting deleterious effects on…

… this signalling axis enhances antitumour immunity and improves immunotherapy efficacy, offering a promising therapeutic strategy for SLD-HCC…

…ctive analysis of patients with malignant melanoma who received immunotherapy at our institution. Real world treatment patterns, irAE, and ou…

…Background Immunotherapy has become an essential therapeutic strategy in the treatment o…

…rating public and real-world multi-omics datasets to accelerate immunotherapy target discovery and validation across solid and hematological …

…en JBAG, Blank CU, Beets-Tan RGH. Predicting response to cancer immunotherapy using noninvasive radiomic biomarkers. Ann Oncol. 2019; 30:998–…

… remain underexplored. This study evaluates trends in inpatient immunotherapy use, outcomes, and resource utilization using a large, national…